Importantly, 3/5 PTEN-null PD1 PROGs were derived from the brain, and analysis of the eight PD1 PROG cell lines derived from brain metastases revealed that all were innate progressing lesions and 5/7 matched tumor dissociates with flow cytometry data had low immune cell infiltration (CD45+ <12% median, Table 1, Fig. 3A). The gene discussed is PTPRC; the disease is neoplasm.